← Leaderboards
Muneesh Tewari
Dana-Farber Cancer Institute
$11,767,255
Attributed
$13,349,049
Total exposure
8
Grants
8
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.6M · FY2005–24$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$17,632,030 · 9
By mechanism
P01$6,471,232 · 2
R01$4,039,146 · 1
U01$3,314,704 · 1
R33$1,153,665 · 1
P50$1,051,036 · 1
K08$622,191 · 1
Top collaborators
- Charles Drescher5 shared
- Robert C Gentleman5 shared
- Nils G Walter4 shared
- Pavan Reddy2 shared
Most similar at Dana-Farber Cancer Institute
Same institution · by research overlap
- William C Hahn$46,384,528
- Jeffrey S Friedman$6,870,136
- David B. Miklos$5,009,214
- Robert C Gentleman$5,480,941
Others in their field
Top investigators on “Base”
- Sonia M Thomas · Research Triangle Institute$700,865,642
- David Heimbrook · Leidos Biomedical Research, Inc.$613,567,095
- David Divins · Consortium For Ocean Leadership, Inc$609,772,544
- Larry Arthur$521,411,998
- Leonard Freedman · Leidos Biomedical Research, Inc.$515,995,429
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$507,042,060
Research focus
BaseTissuesCellsTechnologyMalignant NeoplasmsPlasmaBloodHormonesBiologyMonitorOrganGene ExpressionMicrornasDesignResearch PersonnelSiteMemberGenomicsBlood CirculationOperative Surgical ProceduresMedicineBiologicalMouse ModelLaboratories
Grant awards (45)
Host and Microbial Metabolism in Graft versus Host Disease$2,092,435
P01 · FY2024 · HL · contact PI
Clinical trial exploring the diet-microbiome axis in allo-HCT patients$409,459
P01 · FY2024 · HL · contact PI
Host and Microbial Metabolism in Graft versus Host Disease$2,190,546
P01 · FY2023 · HL · contact PI
Clinical trial exploring the diet-microbiome axis in allo-HCT patients$428,888
P01 · FY2023 · HL · contact PI
Clinical trial exploring the diet-microbiome axis in allo-HCT patients$439,635
P01 · FY2022 · HL · contact PI
Translational & Clinical Research (TACR) Program$67,505
P30 · FY2022 · CA · contact PI
Clinical trial exploring the diet-microbiome axis in allo-HCT patients$450,069
P01 · FY2021 · HL · contact PI
Translational & Clinical Research (TACR) Program$68,762
P30 · FY2021 · CA · contact PI
Highly specific, amplification-free, single-molecule counting of rare methylated DNA cancer biomarkers$608,541
R21 · FY2020 · CA · contact PI
Clinical trial exploring the diet-microbiome axis in allo-HCT patients$460,200
P01 · FY2020 · HL · contact PI
Optimization and Validation of Single-Molecule Kinetic Fingerprinting Technology for Rapid, Ultra-Specific Detection of Cancer Mutations$388,440
R33 · FY2020 · CA · contact PI
Translational & Clinical Research (TACR) Program$68,762
P30 · FY2020 · CA · contact PI
Optimization and Validation of Single-Molecule Kinetic Fingerprinting Technology for Rapid, Ultra-Specific Detection of Cancer Mutations$376,785
R33 · FY2019 · CA · contact PI
Translational & Clinical Research (TACR) Program$68,760
P30 · FY2019 · CA · contact PI
Reference Profiles of ExRNA in Biofluids from Well-Defined Human Cohorts$645,257
U01 · FY2018 · HL · contact PI
Optimization and Validation of Single-Molecule Kinetic Fingerprinting Technology for Rapid, Ultra-Specific Detection of Cancer Mutations$388,440
R33 · FY2018 · CA · contact PI
Translational & Clinical Research (TACR) Program$68,725
P30 · FY2018 · CA · contact PI
Translational & Clinical Research (TACR) Program$9,970
P30 · FY2018 · CA · contact PI
Translational & Clinical Research (TACR) Program$8,971
P30 · FY2018 · CA · contact PI
Translational & Clinical Research (TACR) Program$7,661
P30 · FY2018 · CA · contact PI
Translational & Clinical Research (TACR) Program$2,399
P30 · FY2018 · CA · contact PI
Reference Profiles of ExRNA in Biofluids from Well-Defined Human Cohorts$645,257
U01 · FY2017 · HL · contact PI
Reference Profiles of ExRNA in Biofluids from Well-Defined Human Cohorts$645,257
U01 · FY2016 · HL · contact PI
Reference Profiles of ExRNA in Biofluids from Well-Defined Human Cohorts$645,257
U01 · FY2015 · HL · contact PI
RNA as a Hormone: Systemic Signaling in Mammals via Circulating, Cell-Free Small$143,352
R01 · FY2015 · DK · contact PI
Reference Profiles of ExRNA in Biofluids from Well-Defined Human Cohorts$72,550
U01 · FY2015 · HL · contact PI
Reference Profiles of ExRNA in Biofluids from Well-Defined Human Cohorts$661,126
U01 · FY2014 · HL · contact PI
RNA as a Hormone: Systemic Signaling in Mammals via Circulating, Cell-Free Small$574,964
R01 · FY2014 · DK · contact PI
RNA as a Hormone: Systemic Signaling in Mammals via Circulating, Cell-Free Small$290,724
R01 · FY2013 · DK · contact PI
RNA as a Hormone: Systemic Signaling in Mammals via Circulating, Cell-Free Small$288,380
R01 · FY2013 · DK · contact PI
MicroRNA Signature of Poorly Resectable Ovarian Cancer$191,673
P50 · FY2013 · CA · contact PI
RNA as a Hormone: Systemic Signaling in Mammals via Circulating, Cell-Free Small$666,287
R01 · FY2012 · DK · contact PI
MicroRNA Signature of Poorly Resectable Ovarian Cancer$210,995
P50 · FY2012 · CA · contact PI
RNA as a Hormone: Systemic Signaling in Mammals via Circulating, Cell-Free Small$682,561
R01 · FY2011 · DK · contact PI
MicroRNA Signature of Poorly Resectable Ovarian Cancer$200,810
P50 · FY2011 · CA · contact PI
RNA as a Hormone: Systemic Signaling in Mammals via Circulating, Cell-Free Small$3,520
R01 · FY2011 · DK · contact PI
RNA as a Hormone: Systemic Signaling in Mammals via Circulating, Cell-Free Small$692,958
R01 · FY2010 · DK · contact PI
MicroRNA Signature of Poorly Resectable Ovarian Cancer$219,457
P50 · FY2010 · CA · contact PI
RNA as a Hormone: Systemic Signaling in Mammals via Circulating, Cell-Free Small$696,400
R01 · FY2009 · DK · contact PI
MicroRNA Signature of Poorly Resectable Ovarian Cancer$228,101
P50 · FY2009 · CA · contact PI
Identifying New Aging and Longevity Genes in Caenorhabditis elegans$123,660
K08 · FY2007 · AG · contact PI
Identifying New Aging and Longevity Genes in C. elegans$123,660
K08 · FY2006 · AG · contact PI
Identifying New Aging and Longevity Genes in C. elegans$125,037
K08 · FY2005 · AG
Identifying New Aging and Longevity Genes in C. elegans$125,037
K08 · FY2004 · AG
Identifying New Aging and Longevity Genes in C. elegans$124,797
K08 · FY2003 · AG